Fidelity Disruptive Medicine ETF Rating $24.60 -0.30 (-1.19%) Closing price 09/12/2025 03:33 PM EasternExtended Trading$24.60 0.00 (0.00%) As of 09/12/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestTrendsBuy This Stock Fidelity Disruptive Medicine ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FMED Aggregate RatingModerate Buy 2.86Holdings in FMED have an aggregate rating of Moderate Buy based on 424 analyst ratings issued in the past year covering 22 companies (60.4% of the portfolio).FMED Aggregate Price Target$24.60High Prediction$24.60Average Prediction$24.60Low Prediction$24.60Holdings in FMED have an aggregate price target of $24.60 and a range of $24.60 to $24.60 covering 22 companies (60.4% of the portfolio).FMED Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy5 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold0 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Fidelity Disruptive Medicine ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 22 FMED Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.41%BSXBoston Scientific$102.71-1.6%4.7791 of 5 stars3.08$118.04 14.9%26Trending NewsAnalyst ForecastAnalyst Revision5.24%ALNYAlnylam Pharmaceuticals$465.89-0.6%3.7012 of 5 stars2.85$421.28 -9.6%27Positive NewsAnalyst ForecastInsider Trade3.98%ARGXargenex$756.38-0.9%3.8774 of 5 stars3.04$772.84 2.2%23News CoverageAnalyst Downgrade3.74%PODDInsulet$341.78+1.1%4.4869 of 5 stars2.89$335.12 -1.9%18News CoveragePositive NewsInsider Trade3.47%DHRDanaher$190.07-2.6%4.9916 of 5 stars2.85$246.35 29.6%20News CoveragePositive NewsDividend Announcement3.34%VEEVVeeva Systems$276.21-1.2%4.3605 of 5 stars2.60$301.48 9.1%25Positive News3.13%PENPenumbra$273.54-1.0%4.5554 of 5 stars2.88$302.93 10.7%17Positive News3.09%WAYWaystar$37.36-2.6%4.4457 of 5 stars3.21$44.67 19.6%14Trending NewsInsider Trade2.78%ISRGIntuitive Surgical$449.68-1.4%4.9336 of 5 stars2.60$595.95 32.5%20News CoveragePositive News2.70%LEGNLegend Biotech$33.11-2.1%3.1903 of 5 stars2.91$74.22 124.2%112.69%EXASExact Sciences$53.94-3.7%4.7917 of 5 stars2.88$68.05 26.2%24Trending NewsAnalyst ForecastShort Interest ↓Analyst Revision2.55%EWEdwards Lifesciences$77.50-0.7%4.6351 of 5 stars2.67$86.26 11.3%24News CoveragePositive NewsAnalyst DowngradeShort Interest ↑2.49%SYKStryker$383.32-1.4%4.935 of 5 stars2.78$431.42 12.5%18News CoveragePositive News2.18%MASIMasimo$147.44+0.8%4.7232 of 5 stars3.00$194.60 32.0%7Trending NewsAnalyst Forecast1.96%LFSTLifeStance Health Group$5.23-2.1%3.5054 of 5 stars2.86$8.50 62.5%7Positive News1.73%LLYEli Lilly and Company$754.90-0.2%4.9965 of 5 stars2.68$941.35 24.7%22Trending News1.73%TMOThermo Fisher Scientific$479.48-2.4%4.9713 of 5 stars2.77$592.24 23.5%22Trending NewsAnalyst UpgradeInsider TradeAnalyst Revision1.69%MRUSMerus$69.58-0.3%2.8855 of 5 stars3.08$88.75 27.6%12Positive NewsHigh Trading Volume1.66%DXCMDexCom$76.22+0.3%4.9685 of 5 stars2.91$99.89 31.1%22Positive News1.62%RMDResMed$270.67-1.4%4.6638 of 5 stars2.82$278.36 2.8%17News CoveragePositive News1.59%UNHUnitedHealth Group$352.61-0.3%4.8861 of 5 stars2.52$358.95 1.8%25Trending NewsAnalyst ForecastOptions Volume1.58%DOCSDoximity$71.05+1.1%3.2408 of 5 stars2.61$67.00 -5.7%23News CoveragePositive NewsAnalyst Forecast This page (NASDAQ:FMED) was last updated on 9/14/2025 by MarketBeat.com Staff From Our PartnersNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored6-Figure Target for BTC by 2025The U.S. just announced it's putting GDP data directly onto Bitcoin and Ethereum blockchains. Could this spa...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone thought he was insane…SpaceX just struck a $17 billion deal with EchoStar for radio frequencies, and tech analyst Jeff Brown says it...Brownstone Research | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWall Street Legend Issues Urgent AI Stock Warning'Hidden AI' is taking the U.S. stock market by storm.Chaikin Analytics | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fidelity Disruptive Medicine ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Fidelity Disruptive Medicine ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
